Global Biological Safety Testing Market to Grow at a CAGR of 13.2% During 2024-2032, Aided by the Stringent Government Regulations Aimed Towards Boosting the Safety in Healthcare Institutes

The market for biological safety testing is driven by the stringent government regulations across various countries to bolster the safety and sanitation of healthcare settings. This can be attributed to the rising cases of hospital acquired contaminations, especially among the geriatrics. In addition to this, the increasing prevalence of cancer and diabetes mellitus is anticipated to augment the market growth in the forecast period. Moreover, the advancements in gene therapy, supported by the growing research and development activities, are likely to propel the demand for these tests in the forecast period.

Charles River Laboratories, Inc. (NYSE: CRL), one of the leading market players, offers a detection tool known as EndoScan-V™. The tool is an endotoxin analysis and measuring software that delivers and reports quantitative test data, further helping achieve the long-term safety of a manufacturing environment.

In terms of region, North America is likely to account for a significant share of the market and is anticipated to witness a healthy growth in the forecast period. The market in the region is driven by the rising cases of chronic disorders, rising demand for safety testing kits in hospitals and clinics, and the growing awareness pertaining to the product safety especially after the outbreak of COVID-19. Furthermore, the growing FDA approvals of various biosimilars in the region are anticipated to further augment the market growth in the coming years.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Breakup by Product, Application, Test Type and Region:

• The market is segmented based on product into reagents and kits, services, and instruments.

• Based on application, the market is divided into stem cell, tissue and tissue-based products, gene therapy, blood and blood-based products, and vaccines and therapeutics.

• The segmentation of the market based on test type includes sterility tests, cell line authentication and characterisation tests, bioburden tests, endotoxin tests, adventitious agent detection tests, and residual host contamination detection tests, among others.

• Region-wise, the global market for biological safety testing can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The rising application of biological safety testing in gene therapy and vaccines and therapeutics is driving the growth of the market.

• The thriving biopharmaceutical and healthcare sector especially in emerging economies is anticipated to bolster the market growth in the forecast period.

• The rising FDA approvals of biosimilars, owing to the patent expiry of the existing ones, are likely to augment the market growth.

• The market is further expected to be aided by the rising cases of chronic diseases including cancer and the stringent government regulations to improve the safety standards in the healthcare sector.

Key Offerings of the Report:

• The EMR report gives an overview of the global market for biological safety testing for the periods (2018-2023) and (2024-2032).

• The report also offers historical (2018-2023) and forecast (2024-2032) market information for the products, applications, test types, and major regions of biological safety testing.

• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global biological safety testing market are Charles River Laboratories International, Inc., Toxikon Corporation, Avance Biosciences, Merck KGaA, and SGS SA, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790